Anastrozole
Nonsteroidal aromatase inhibitor; blocks estrogen biosynthesis
Mechanism of Action
Anastrozole is a potent, selective nonsteroidal aromatase inhibitor (type III). It competitively binds to the heme group of cytochrome P450 aromatase (CYP19A1), preventing the conversion of androstenedione and testosterone to estrone and estradiol. This reduces circulating estrogen levels by up to 80% or more. Anastrozole does not affect adrenal steroidogenesis or cortisol/aldosterone production. In research contexts, it is studied for estrogen management during androgen administration and for estrogen-sensitive conditions.
Evidence Chain
Anastrozole
COMPOUND
1 Research Goal
• Sexual Health & Libido
Evidence Strength
6 articles sourced
Knowledge Graph
(7 connections)Research Goals
(1)Research Evidence
(6)Clomiphene Citrate: Evidence-Based Research Review
Clomiphene citrate (CC) is a non-steroidal triphenylethylene derivative classified as a Selective Estrogen Receptor Modulator (SERM). Originally developed for the induction of ovulation in women with anovulatory infertility, it has become a cornerstone of reproductive medicine. CC operates as a race
Testosterone Enanthate: Evidence-Based Research Review
Testosterone enanthate (TE) is a long-acting esterified formulation of the primary endogenous androgen, testosterone. Since its clinical introduction in the 1950s, it has served as a cornerstone for testosterone replacement therapy (TRT) in male hypogonadism and a reference compound in clinical rese
Raloxifene: Evidence-Based Research Review
Raloxifene is a second-generation selective estrogen receptor modulator (SERM) of the benzothiophene class. Developed to address the limitations of first-generation SERMs like tamoxifen, raloxifene exhibits distinct tissue-specific effects: it acts as an estrogen receptor (ER) agonist in bone and li
BPC-157 and Tissue Repair Signaling Pathways
Comprehensive review of BPC-157 mechanisms in tissue repair, angiogenesis, and mucosal healing.
Boldenone Undecylenate: Evidence-Based Research Review
Boldenone undecylenate, a synthetic derivative of testosterone originally developed for veterinary use, is a long-acting injectable anabolic-androgenic steroid (AAS). Characterized by a double bond between the C1 and C2 positions, the compound exhibits a favorable ratio of anabolic to androgenic act
Trenbolone Acetate: Evidence-Based Research Review
Trenbolone acetate (TBA) is a potent synthetic 19-nortestosterone derivative classified as an anabolic-androgenic steroid (AAS). Originally developed for veterinary applications—specifically to increase muscle mass and feed efficiency in beef cattle—TBA has become a focal point of pharmacological in
Related Compounds
Synergy & Compatibility
(5)Computational assessment of bio-regulatory compatibility with compounds sharing research goals. Scores reflect half-life alignment, receptor target overlap, and bioavailability data.
Highest Compatibility
Anastrozole + Raloxifene
Moderate Compatibility
Shared targets: aromatase (cyp19a1)
Computational assessment based on available pharmacology data. Does not account for individual variability, dose-dependent effects, or unstudied interactions. For research use only.
Community Observations
(0)Qualitative, self-reported researcher observations. Distinct from peer-reviewed evidence — not medical advice.
No approved observations yet. Sign in to contribute.
For research use only. Not medical advice.